Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises
Executive Summary
Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.
You may also be interested in...
UK Launches Inquiry Into Its Clinical Trials Problems After Pharma Outcry
Stung by criticism from the AstraZeneca and GSK CEOs, the UK government has launched an independent review into commercial clinical trials in the hopes of reversing a steep decline.
Industry Calls For Urgent Action As UK Drops In Global Ranking For Clinical Trials
The UK’s research-based industry association has issued a dire warning over the UK’s “deteriorating ability to attract and deliver industry clinical trials.”
New UK Model Agreements To Streamline Clinical Research
Efforts are on to reduce the time it takes to set up commercial studies in UK hospitals.